Sagimet Biosciences - Suspends And Terminates ATM Prospectus Supplement For Series A Common Stock Effective Sept 30
Sagimet Biosciences Inc. NASDAQ:SGMT
Story updates
10:19:19 AM UTC
SquawkNews
SGMT - Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants